Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Immune-regulating strategy against rheumatoid arthritis by inducing tolerogenic dendritic cells with modified zinc peroxide nanoparticles

Fig. 2

DCs targeting delivery of nontoxic ZnCM NPs in vitro. a Cell viabilities of DCs after varying NPs treatments. b In vitro CLSM observations of DCs treated with nontoxic ZnC (left) and ZnCM (right) NPs after 2 h. c In vitro Bio-TEM investigations of DCs treated with nontoxic ZnC and ZnCM NPs after 2 h. The red arrow indicated the intracellular localization of NPs in DCs. d Characterizations of route for NPs uptake by varying endocytosis inhibitors on DCs treated with nontoxic ZnCM NPs. ** indicated the significant difference of p ≤ 0.05 compared with Ctrl

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us